Skip to main content

Table 2 The p values for the differences in treatment options for patients who died or had a relapse (n = 57) according to their dichotomized density profiles

From: Prognostic contribution of mammographic breast density and HER2 overexpression to the Nottingham Prognostic Index in patients with invasive breast cancer

 

VLD vs MID*

Adjuvant chemotherapy

0.398

Herceptin

0.229

Hormonal Therapy

0.419

Radiotherapy

0.762

  1. *VLD very low densiy, MID Mixed density
Back to article page

BMC Cancer

ISSN: 1471-2407

Contact us